Medifast adds Steamboat nominees to board slate to boost stockholder value at May 19, 2026 meeting

Reuters03-20
Medifast adds Steamboat nominees to board slate to boost stockholder value at May 19, 2026 meeting
  • Medifast reached a cooperation agreement with Steamboat Capital, which said it beneficially owns above 5% of the company’s outstanding shares.
  • Board nominations under the agreement include Parsa Kiai and Jeff Rose as independent director candidates for election at the 2026 annual meeting, provisionally scheduled for May 19, 2026.
  • Directors Jeffrey Brown and Michael Hoer are not expected to stand for reelection at that meeting.
  • Steamboat Capital agreed to standstill and voting provisions through the 2027 annual meeting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medifast Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260320613507) on March 20, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment